Dignicap in four different colors Swedish

Results with the DigniCap™ System

The following clinical studies have been conducted to evaluate safety and efficacy with the DigniCap™ System:

  1. Lundgren-Eriksson et al. Total prevention of taxoid-induced alopecia by a new model of cold cap, Eur J Cancer, 1999;35 (suppl 4): 376. 
  2. Henriksen et al. Advanced, computerised cold cap for preventing chemotherapy induced alopecia. Eur J Cancer, 2003;1(5):369. 
  3. Ridderheim et al. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients. Support Care Cancer, 2003;11:371–7. 
  4. Byahov. Alopecia prevention in chemotherapy patients. Methods of controlled scalp cooling. Meditsinskaya Cartoteka, 2006. 
  5. Kato et al. Evaluation of DigniCap™ system for the prevention of chemotherapy induced hair loss in breast cancer patients. Poster: 16th Japanese Breast Cancer Society in Osaka, Sept 26–27, 2008.
Post Market Surveillance Report, 2001-2008. More than 3200 patients have used the DigniCap™ System in Scandinavia, Russia and Japan.
Scalp Cooling
DigniCap™
About Dignitana

Contact Us

Phone: + 46 46-16 30 90
Fax: + 46 46-16 30 99
E-mail: info(snabel-a)dignitana.com

Dignitana AB

Dignitana has developed a patented scalp cooling system, DigniCap™, which prevents chemotherapy induced hair loss. The patented DigniCap™ system has shown excellent results in clinical studies. In terms of efficacy, eight out of ten patients undergoing scalp cooling using the DigniCap™ System kept their hair and the use of wig was not necessary.